E25Bio
E25Bio develops rapid diagnostic tests utilizing nucleic acid amplification techniques to detect epidemic fever viruses in real-time. These tests provide healthcare professionals with timely and accurate results, enabling swift response to outbreaks and improving patient outcomes.
Traction 2/10Founded 2018
Cambridge, United Kingdom · HQ
- Biotechnology
- Healthcare Technology
Updated 2 days ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- E25Bio develops rapid diagnostic tests utilizing nucleic acid amplification techniques to detect epidemic fever viruses in real-time. These tests provide healthcare professionals with timely and accurate results, enabling swift response to outbreaks and improving patient outcomes.